Beijing Jing Kang Pharmaceutic

Beijing Jingkang Pharmaceutical is a specialized pharmaceutical enterprise based in Beijing, China, focusing on the development, production, and commercialization of high-quality generic medications. The company's portfolio primarily targets chronic conditions, with a significant emphasis on metabolic disorders such as diabetes and cardiovascular diseases. Jingkang is particularly recognized for its expertise in oral solid dosage forms, specifically sustained-release and controlled-release formulation technologies. Operating from GMP-certified facilities in the Yanqi Industrial Park, the company serves the domestic Chinese market and engages in international pharmaceutical trade. Its business model integrates research and development with large-scale manufacturing to provide affordable therapeutic options for widespread health issues.